---
figid: PMC12154924__ijms-26-05370-g002
figtitle: Recent Advances in Molecular Research and Treatment for Melanoma in Asian
  Populations
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12154924
filename: ijms-26-05370-g002.jpg
figlink: /pmc/articles/PMC12154924/figure/F2/
number: F2
caption: 'Pathogenic mechanisms and therapeutic targets in melanoma: the figure illustrates
  the RAS–RAF–MEK–MAPK signaling pathway activated by growth factor receptors, highlighting
  how specific genetic mutations contribute to melanoma development and how these
  mutations serve as therapeutic targets for currently available treatments'
papertitle: Recent Advances in Molecular Research and Treatment for Melanoma in Asian
  Populations
reftext: Soichiro Kado, et al. Int J Mol Sci. 2025 Jun;26(11).
year: '2025'
doi: 10.3390/ijms26115370
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: melanoma | immune checkpoint inhibitors | BRAF-MEK inhibitors | acral and
  mucosal melanoma | therapeutic resistance
automl_pathway: 0.9429712
figid_alias: PMC12154924__F2
figtype: Figure
redirect_from: /figures/PMC12154924__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12154924__ijms-26-05370-g002.html
  '@type': Dataset
  description: 'Pathogenic mechanisms and therapeutic targets in melanoma: the figure
    illustrates the RAS–RAF–MEK–MAPK signaling pathway activated by growth factor
    receptors, highlighting how specific genetic mutations contribute to melanoma
    development and how these mutations serve as therapeutic targets for currently
    available treatments'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KIT
  - NTRK1
  - NTRK2
  - NTRK3
  - KDR
  - FLT1
  - FLT4
  - FGF1
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - ROS1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - BRAF
  - ZHX2
  - ARAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - RAS
  - MEK Inhibitors
  - MEK
  - BRAF Inhibitors
---
